Get started
ACADIA PHARMACEUTICALS INC COM STK USD0.0001ACADIA PHARMACEUTICALS INC COM STK USD0.0001ACADIA PHARMACEUTICALS INC COM STK USD0.0001

ACADIA PHARMACEUTICALS INC COM STK USD0.0001

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0A4W trade ideas

ACAD Stock Soared to a Four-Month High. Acadia Pharmaceuticals shares are trading higher Wednesday after the company won summary judgement in a patent suit. Just then Acadia Surged upto 33% in regards to the news. Acadia Pharmaceuticals (ACAD) notched a win in a patent battle Wednesday pertaining to its Parkinson's drug, Nuplazid. ACAD stock soared to a four-month high. ACAD Stock: Cashing In On Nuplazid Nuplazid is an important drug for Acadia. It's currently approved to treat patients with psychosis due to Parkinson's disease. In the September quarter, Nuplazid brought in $144.8 million in sales, accounting for more than 68% of total sales. NASDAQ:ACAD is trading above the 50, 100, & 200-day moving average indicating a Bullish Bias.
NASDAQ:ACADLong
by DEXWireNews
Acadia I had this mapped out but I misse the trade! Damn! What do I do!? We’ll I’ll tell you, I don’t come in here now and FOMO. I draw some fibs and look for previous resiatnce. I see a lot o wicks and no candles closing above .382 from recent high to low of 21.07 This price is 22.48 I have some bids there. I see .618 at 22.14. This is also the low supprt of recent bull flag breakout. These are my levels I’m putting some buy orders out here. If we lost these support there is a big buyer at 21.08 if price does come all the way back down for another gift. This should reach 27.48 AT LEAst c I’ll be swinging this to that price target. Good luck!!
NASDAQ:ACADLong
by Erictaylor
Big move coming, which way is the question..NASDAQ:ACAD .. I have been along with this one for a few months now. Around this price range is where we see big-time moves. This $21.88 level is a key level for this stock. It has been in a downtrend since it hit its 3 month high at the end of December. With how the market has been to begin this year, the downtrend seems more likely to continue. There is a good chance we see a bounce at this level considering there is not much volume until that $21.88 level, but only to again try to break out of this downtrend. I bet we see this big level tested in the next couple of days to see if it breaks down.
NASDAQ:ACAD
by keekthedeek
ACADIA Pharmaceuticals Inc 🧙Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:ACADLong
by unfair_advantage
2
Pull Back FishingLong fall after a disappointing study result, I think? Earnings May 26th. Triple top noted but has fallen more than this structure would measure. No recommendation Sometimes when stocks gap down, price goes up only to fall again (dead cat bounce) so always good to be sure the bottom is the bottom. Gaps down are bearish and even though this gap will most likely fill one day, it is still good to get a healthy long entry level. The market can gravitate toward uncertainty.
NASDAQ:ACAD
by lauralea
ACAD (ACADIA PHARMACEUTICALS INC) BUY ACAD LONG SET UP, ACAD Gapped down over 25% to a New 52 week low. Price should bounce and fill in the Gap in the market ACAD also filled its previous Buy gap from Sep 4th 2019 Title: Buy ACAD (ACADIA Pharmaceuticals) Asset: Stock Platform: Robinhood/WeBull/Etrade/ 401k account Symbol: ACAD Type: Buy Market Execution / Buy Limit Time Frame: 1D Entry Price 1: $26.50 ACTIVE Entry Price 2: $22.50(PENDING) Stop Loss: $19.50 (70 Pips) Take Profit 1: $33.00 (70 pips) Take Profit 2: $38.00 (140 pips) Take Profit 3: $44.00 (200 pips) Take Profit 4: $54.00 (300pips) Status: 🏃🏽‍♂️Active🏃🏽‍♂️ Sector: Health Technology Industry: Biotechnology ACADIA Pharmaceuticals operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R Brann on July 16, 1993 and is headquartered in San Diego CA
NASDAQ:ACADLong
by MavRich_Trading
3
ACAD: Chance for a big pullbackSo what has caused such plummet? I've carried out a research and found out. 😀 Stock has declined due to the simple fact that FDA has requested the specific requirements for the drug labeling. By the way, The drug (Pimavanserin) has already been approved by FDA for quite long time. So in general, regulatory setback was in post-marketing requirements. The situation wasn't as tragic as market has reacted to. The problem has a simple solution. In other words, the company should just mobilize their effort to change the label to the one asked by FDA. Moreover, If you check the production pipeline, you'll see that it's not the only drug the company is making. Definitely waiting for a pullback, or I even dare to call it a recovery. I mean look at the weekly chart on the right. It literally screams for bulls. Left chart shows significant levels for each stop of supposed bullish wave based on fib sequence of initial green candle on the bottom. Fib channel is mounted to the parallel angle of decline on top and bottom patterns. Combo of these two tools will allow to trace the level at which the pullback will be on its reversal stage.
NASDAQ:ACADLong
by fract
4